All News
SS Innovations International makes NASDAQ Debut
SS Innovations International reported revenues reaching $20.6 million for the year ending December 31, 2024, rising by 40.
Read MoreBPL Medical Technologies announces leadership changes
Sunil Khurana is promoted to Executive Chairman, while Dr Shravan Subramanyam assumes the role of MD, and Guruswamy K takes over as the CEO
Read MoreAHPI Delhi Chapter holds executive committee meeting for 2024–25
Dr Mradul Kaushik will now serve as the President, while Mahipal Bhanot and Dr Ajay Bedi assume the role of Vice President
Read MoreGlobalData highlights implications of US tariffs on IVD market
According to GlobalData, these tariffs are expected to impact all 510(k)-approved medical devices manufactured outside of the US
Read MoreWhat ‘Fertilization President’ Trump Can Learn From State Efforts To Expand IVF Access
State-level efforts to regulate fertility coverage reveal the gauntlet of budgetary and political hurdles such initiatives face — obstacles that have led to millions of people being left out even wh
Read MoreMoms in Crisis, Jobs Lost: The Human Cost of Trump’s Addiction Funding Cuts
In many cases, the money flowed to addiction recovery programs that help rebuild lives by driving people to medical appointments and court hearings, crafting résumés and training them for new jobs,
Read MoreSTAT+: Struggling lobbyists, panicked clients: D.C. comes to grips with Trump’s second term
Trump's second term is playing out a lot differently than health care companies and their lobbyists hoped for.
Read MoreSTAT+: With the FDA in turmoil, the ‘revolving door’ with industry is spinning faster
HHS Robert F. Kennedy Jr. has railed against a “revolving door” between drug companies and the FDA. But HHS' actions now seem to be causing that door to spin faster.
Read MoreOpinion: NIH cuts will set back research into the rare disease that has terrorized my family
Jim Higgins has an inherited cancer syndrome that has killed his father, sister, and two daughters. He fears NIH cuts will hurt important research progress made in recent years.
Read More